Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Navidea Biopharmaceuticals (CE) (NAVB)

Navidea Biopharmaceuticals Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:NAVB
DateTimeSourceHeadlineSymbolCompany
06/02/202400:53Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
01/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
01/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
01/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
01/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
01/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:28Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:28Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:28Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:27Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:27Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:27Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:27Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:26Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:26Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:26Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:26Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:26Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:26Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
16/01/202418:53Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
20/11/202323:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
20/11/202323:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
13/11/202319:58Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
16/05/201413:47Dow Jones NewsU.S. Hot Stocks: Hot Stocks to WatchAMEX:NAVBNavidea Biopharmaceuticals Inc.
18/02/201414:18Dow Jones NewsU.S. Hot Stocks: Hot Stocks to WatchAMEX:NAVBNavidea Biopharmaceuticals Inc.
10/12/201314:33Dow Jones NewsU.S. Hot Stocks Futures: Hot Stocks to WatchAMEX:NAVBNavidea Biopharmaceuticals Inc.
24/04/201313:36Dow Jones NewsNavidea Sells More Shares to J.P. Morgan's Asset Management Unit and Another Institutional InvestorAMEX:NAVBNavidea Biopharmaceuticals Inc.
 Showing the most relevant articles for your search:USOTC:NAVB